The US Food and Drug Administration (FDA) has granted 510(k) clearance to SomnoMed's SomnoDent G2 technology. SomnoDent G2 includes modular adjustment parts and features 'Click to Fit' design which provides controlled measurement of a ...
Tags: SomnoDent G2 technology, diagnostic solution, medical solution
The company said that the new division will research and develop specialized minimally invasive devices required for non-surgical procedures in otolaryngology to treat traditional ear, nose and throat (ENT) conditions. With an objective ...
Tags: OHNS, salivary gland disease, chronic sinusitis, vocal cord paralysis
Teva Pharmaceutical Industries has entered into a settlement agreement related to Nuvigil patent infringement litigation with Mylan. Under the agreement, Mylan is allowed to sell generic versions of 50mg, 150mg, and 250mg Nuvigil in June ...
Tags: Nuvigil, armodafinil tablets, Teva Pharmaceutical Industries, Mylan
Mylan's subsidiary, Mylan Pharmaceuticals, has settled Provigil litigation with Teva Pharmaceutical USA. The settlement follows the Mylan litiagtion against the US Food and Drug Administration (FDA) regarding Mylan's abbreviated new drug ...
The US Food and Drug Administration (FDA) has granted final approval to Mylan Pharmaceuticals' abbreviated new drug application (ANDA) of Modafinil tablets USP,100 mg and 200 mg. Modafinil USP,100 mg and 200 mg tablets are generic ...